Pyranose Glycals to Furanose Derivatives
J . Org. Chem., Vol. 63, No. 24, 1998 9043
Hz), 4.43 (ddd, 1 H, J ) 4.7, 5.9, 7.4 Hz), 4.20 (dd, 1 H, J )
4.7, 11.7 Hz), 4.12 (dd, 1 H, J ) 7.4, 11.7 Hz), 4.02-3.95 (m,
2 H), 3.75-3.66 (m, 2 H), 3.55-3.49 (m, 2 H), 3.36 (s, 3 H),
2.06 (s, 3 H), 2.05 (s, 3 H), 1.96 (s, 3 H); 13C NMR (75.5 MHz,
CDCl3, δ) 170.46, 169.41, 169.18, 138.64, 138.11, 138.04,
128.37, 128.34, 128.30, 127.08, 127.82, 127.76, 127.69, 127.49,
104.71, 98.02, 81.88, 79.79, 77.42, 75.63, 75.38, 74.94, 73.35,
70.96, 69.71, 66.52, 62.80, 55.10, 20.57, 20.44, 20.31. Anal.
Calcd for C39H46O13: C, 64.81; H, 6.41. Found: C, 64.56; H,
6.39.
Meth yl 5-O-(2,3,5-Tr i-O-a cetyl-r-D-a r a bin ofu r a n osyl)-
2,3-d i-O-ben zoyl-r-D-a r a bin ofu r a n osid e (25). Chromatog-
raphy (toluene/EtOAc, 9:1) yielded the product as a clear
syrup: Rf 0.18 (toluene/EtOAc, 9:1); [R]D +19.2° (c 3.7, CHCl3);
1H NMR (300 MHz, CDCl3, δ) 8.11-7.26 (m, 10 H), 5.61 (d, 1
H, J ) 4.8 Hz), 5.49 (s, 1 H), 5.22 (s, 1 H), 5.21 (s, 1 H), 5.14
(s, 1 H), 4.94 (d, 1 H, J ) 4.5 Hz), 4.48-4.33 (m, 3 H), 4.22
(dd, 1 H, J ) 5.4, 11.4 Hz), 4.12 (dd, 1 H, J ) 3.3, 10.5 Hz),
3.85 (d, 1 H, J ) 12 Hz), 3.47 (s, 3 H), 2.09, 2.07, 1.87 (3s, 9
H); 13C NMR (75.5 MHz, CDCl3, δ) 170.61, 170.31, 169.41,
165.72, 165.49, 133.60, 133.48, 129.94, 129.90, 129.28, 129.22,
128.60, 128.50, 106.83, 105.45, 82.19, 81.49, 81.14, 80.90,
77.37, 76.99, 65.42, 63.31, 54.92, 20.80, 20.76, 20.47. Anal.
Calcd C31H34O14: C, 57.40; H, 5.61. Found: C, 57.74; H, 5.49.
Anal. Calcd for C40H48O13Si: C, 62.81; H, 6.32. Found: C,
62.94; H, 6.46.
Meth yl 3-O-(2,3,5-Tr i-O-a cetyl-r-D-lyxofu r a n osyl)-5-O-
ter t-bu tyld ip h en ylsilyl-2-O-ben zoyl-r-D-a r a bin ofu r a n o-
sid e (29). Purification by chromatography (hexane/EtOAc,
2:1) gave the product as a colorless syrup: Rf 0.41 (hexane/
1
EtOAc, 2:1); [R]D +62.0° (c 1.1, CHCl3); H NMR (300 MHz,
CDCl3, δ) 7.99 (m, 2 H), 7.70 (m, 4 H), 7.57 (m, 1 H), 7.43-
7.32 (m, 8 H), 5.56 (t, 1 H, J ) 5.5 Hz), 5.43 (d, 1 H, J ) 1.6
Hz), 5.30 (dd, 1 H, J ) 1.7, 5.2 Hz), 5.24 (d, 1 H, J ) 1.2 Hz),
5.09 (s, 1 H), 4.39 (m, 1 H), 4.24-4.11 (m, 3 H), 4.03 (dd, 1 H,
J ) 7.3, 11.5 Hz), 3.94 (dd, 1 H, J ) 4.7, 11.3 Hz), 3.87 (dd, 1
H, J ) 3.6, 11.3 Hz), 3.44 (s, 3 H), 2.09 (s, 3 H), 2.07 (s, 3 H),
1.90 (s, 3 H), 1.03 (s, 9 H); 13C NMR (75.5 MHz, CDCl3, δ)
170.33, 169.36, 169.20, 165.49, 135.54, 135.49, 133.26, 133.23,
129.74, 129.60, 129.57, 129.20, 128.28, 127.59, 127.54, 106.84,
103.77, 83.26, 82.63, 80.80, 75.40, 75.33, 70.79, 62.91, 62.50,
54.53, 26.62, 20.48, 20.39, 20.27, 19.20. Anal. Calcd for
C
40H48O12Si‚0.5H2O: C, 62.07; H, 6.31. Found: C, 62.13; H,
6.21.
Meth yl r-D-Ar a bin ofu r a n osyl-(1f5)-r-D-a r a bin ofu r a -
n osid e (30). Disaccharide 25 (160 mg, 0.25 mmol) dissolved
in dry CH3OH (5 mL) was treated with a catalytic amount of
sodium methoxide. The mixture was stirred for 4 h and then
neutralized with prewashed Amberlite IR-118 (H+) resin. The
solution was filtered, and the resulting residue was taken up
in CH2Cl2. The product was extracted into water, and the
water layer was concentrated. Purification by column chro-
matography (CHCl3/CH3OH, 3:1) yielded 30 (67 mg, 90%) as
a clear syrup: [R]D -157° (c 1.6, H2O); Rf 0.7 (CHCl3/CH3OH,
2:1); 1H NMR (600 MHz, D2O, δ) 4.99 (d, 1 H, J ) 1.5 Hz,
H-1′), 4.85 (d, 1 H, J ) 1.5 Hz, H-1), 4.08 (ddd, 1 H, J ) 5.5,
3.4, 5.8 Hz, H-4), 4.04 (dd, 1 H, J ) 1.3, 3.1 Hz, H-2′), 4.01
(ddd, 1 H, J ) 5.5, 3.4, 6.1 Hz, H-4′), 3.98 (dd, 1 H, J ) 1.5,
3.1 Hz, H-2), 3.92 (dd, 1 H, J ) 3.1, 5.8 Hz, H-3), 3.87 (dd, 1
H, J ) 3.1, 6.1 Hz, H-3′), 3.80 (dd, 1 H, J ) 5.5, 11.3 Hz, H-5R),
3.74 (dd, 1 H, J ) 3.4, 12.5 Hz, H-5′S), 3.72 (dd, 1 H, J ) 3.4,
11.3 Hz, H-5S), 3.63 (dd, 1 H, J ) 5.5, 12.5 Hz, H-5′R), 3.34
(s, 3 H, OCH3); 13C NMR (125 MHz, D2O, δ) 109.31 (C-1),
108.31 (C-1′), 84.87 (C-4′), 83.14 (C-4), 81.79 (C-2′), 81.49 (C-
2′), 77.46 (C-3), 77.43 (C-3′), 67.73 (C-5), 62.08 (C-5′), 55.88
(OCH3) HR-FABMS m/z calcd for [C11H20O9]H+ 297.1185,
found 297.1174.
Meth yl 5-O-(2,3,5-Tr i-O-a cetyl-r-D-lyxofu r a n osyl)-2,3-
d i-O-ben zoyl-r-D-a r a bin ofu r a n osid e (26). Chromatogra-
phy (hexane/EtOAc, 1:1) gave the product as a syrup: Rf 0.44
1
(hexane/EtOAc, 1:1); [R]D +26° (c 1.6, CHCl3); H NMR (300
MHz, CDCl3, δ) 8.07-7.40 (m, 10 H), 5.57 (t, 1 H, J ) 5.6 Hz),
5.45 (m, 2 H), 5.31 (dd, 1 H, J ) 1.5, 5.2 Hz), 5.21 (d, 1 H, J
) 1.2 Hz), 5.13 (s, 1 H), 4.53 (m, 1 H), 4.37 (m, 1 H), 4.23 (dd,
1 H, J ) 4.9, 11.7 Hz), 4.19 (dd, 1 H, J ) 4.4, 11.8 Hz), 4.11
(dd, 1 H, J ) 4.8, 11.1 Hz), 3.90 (dd, 1 H, J ) 3.2, 11.2 Hz),
3.47 (s, 3 H), 2.05 (s, 6 H), 2.03 (s, 3 H); 13C NMR (75.5 MHz,
CDCl3, δ) 170.48, 169.30, 169.16, 165.60, 165.35, 133.44,
133.35, 129.80, 129.72, 129.11, 128.99, 128.50, 128.36, 106.76,
104.69, 81.95, 81.35, 77.37, 75.46, 75.42, 70.94, 66.93, 62.63,
54.88, 20.65, 20.38, 20.26. Anal. Calcd for C31H34O14‚H2O: C,
57.41; H, 5.59. Found: C, 57.13; H, 5.24.
Octyl 5-O-(2,3,5-Tr i-O-a cetyl-r-D-lyxofu r a n osyl)-2,3-d i-
O-ben zyl-r-D-a r a bin ofu r a n osid e (27). Chromatography
(hexane/EtOAc, 1:1) gave the product as a colorless syrup: Rf
1
0.71 (hexane/EtOAc, 1:1); [R]D +83° (c 1.3, CHCl3); H NMR
Meth yl r-D-Lyxofu r a n osyl-(1f5)-r-D-a r a bin ofu r a n o-
sid e (31). Disaccharide 18 (55 mg, 0.09 mmol) was dissolved
in dry CH3OH (5 mL), and then 0.1 M methanolic NaOCH3
(0.5 mL) was added dropwise. After 4 h, the reaction mixture
was neutralized with Amberlite IR-118 (H+) resin, filtered, and
evaporated, and the residue was chromatographed (CHCl3/
CH3OH, 2:1) to give 31 (18 mg 69%) as a syrup: Rf 0.56
(CHCl3/CH3OH, 2:1); [R]D +136° (c 1.1, H2O); 1H NMR (300
MHz, D2O, δ) 4.97 (d, 1 H, J ) 3.2 Hz, H-1′), 4.80 (d, 1 H, J )
1.1 Hz, H-1), 4.26 (t, 1 H, J ) 4.6 Hz, H-3′), 4.17 (td, 1 H, J )
4.3, 6.6 Hz, H-4′), 4.05 (dd, 1 H, J ) 3.3, 4.8 Hz, H-2′), 4.01
(dt, 1 H, J ) 3.4, 5.7 Hz, H-4), 3.93 (dd, 1 H, J ) 1.7, 3.3 Hz,
H-2), 3.85 (dd, 1 H, J 3.3, 5.8 Hz, H-3), 3.75 (dd, 1 H, J ) 5.6,
11.4 Hz, H-5R), 3.71 (dd, 1 H, J ) 4.2, 11.9 Hz, H-5′S), 3.67
(dd, 1 H, J ) 3.1, 10.9 Hz, H-5S), 3.62 (dd, 1 H, J ) 6.6, 11.9
Hz, H-5′R), 3.28 (s, 3 H, OCH3); 13C NMR (75.5 MHz, D2O, δ)
108.38 (C-1), 107.13 (C-1′), 82.21 (C-4), 80.69 (C-2), 80.39 (C-
4′), 76.54 (C-3), 75.95 (C-2′), 71.03 (C-3′), 67.59 (C-5), 60.19
(C-5′), 55.03 (OCH3). HR-FABMS m/z calcd for [C11H20O9]-
Na+ 319.1005, found 319.0996.
(300 MHz, CDCl3, δ) 7.36-7.26 (m, 10 H), 5.54 (t, 1 H, J ) 5.6
Hz), 5.25 (dd, 1 H, J ) 1.7, 5.1 Hz), 5.13 (d, 1 H, J ) 1.6 Hz),
5.01 (d, 1 H, J ) 1.0 Hz), 4.59 (d, 2 H, J ) 11.9 Hz), 4.50 (d,
1 H, J ) 11.9 Hz), 4.49 (d, 1 H, J ) 11.9 Hz), 4.41 (ddd, 1 H,
J ) 4.8, 6.0, 7.3 Hz), 4.21 (dd, 1 H, J ) 4.7, 11.7 Hz), 4.15 (dd,
1 H, J ) 7.4, 11.5 Hz), 4.13 (ddd, 1 H, J ) 3.5, 4.6, 7.1 Hz),
4.01 (dd, 1 H, J ) 1.4, 3.5 Hz), 3.88 (dd, 1 H, J ) 3.4, 6.9 Hz),
3.83 (dd, 1 H, J ) 4.8, 11.2 Hz), 3.70 (dt, 1 H, J ) 6.7, 9.6 Hz),
3.66 (dd, 1 H, J ) 3.5, 11.2 Hz), 3.38 (dt, 1 H J ) 6.6, 9.6 Hz),
2.06 (s, 3 H), 2.05 (s, 6 H), 1.61-1.55 (m, 2 H), 1.33-1.27 (m,
10 H), 0.88 (t, 3 H, J ) 6.9 Hz); 13C NMR (75.5 MHz, CDCl3,
δ) 170.49, 169.38, 169.18, 137.74, 137.46, 128.33, 128.29,
127.83, 127.75, 127.67, 105.98, 104.62, 88.16, 83.14, 79.7,
75.30, 75.24, 72.06, 71.90, 70.98, 67.65, 67.20, 62.78, 31.73,
29.41, 29.27, 29.17, 26.02, 22.55, 20.68, 20.40, 20.29, 14.00.
Anal. Calcd for C38H52O12: C, 65.13; H, 7.48. Found: C, 64.96;
H, 7.44.
Meth yl 3-O-(2,3,5-Tr i-O-a cetyl-r-D-a r a bin ofu r a n osyl)-
5-O-ter t-bu tyld ip h en ylsilyl-2-O-ben zoyl-r-D-a r a bin ofu r a -
n osid e (28). Chromatography (hexane/EtOAc, 9:1) gave 11
(477 mg, 79%) as a syrup: Rf 0.35 (hexane/EtOAc, 6:1); [R]D
+20.3° (c 0.5, CHCl3); 1H NMR (300 MHz, CDCl3, δ) 7.99-
7.97 (m, 2 H), 7.70-7.53 (m, 4 H), 7.42-7.26 (m, 7 H), 5.40 (s,
1 H), 5.30 (d, 1 H, J ) 1.2 Hz), 5.18 (d, 1 H, J ) 1.6 Hz), 5.09
(s, 1 H), 4.97 (dd, 1 H, J ) 1.6, 5.1 Hz), 4.46 (m, 1 H), 4.26-
4.04 (m, 4 H), 3.89-3.87 (m, 2 H), 3.44 (s, 3 H), 2.10 (s, 3 H),
2.08 (s, 3 H), 1.96 (s, 3 H), 1.03 (s, 9 H); 13C NMR (75.5 MHz,
CDCl3, δ) 170.49, 170.01, 169.48, 165.59, 135.64, 135.59,
133.36, 133.29, 129.87, 129.77, 129.70, 129.34, 128.39, 127.72,
127.66, 127.27, 107.14, 104.81, 84.94, 83.21, 82.60, 81.19,
80.47, 79.97, 77.22, 63.05, 62.94, 54.74, 26.74, 20.75, 19.33.
Octyl r-D-Lyxofu r a n osyl-(1f5)-r-D-a r a bin ofu r a n osid e
(32). A solution of 21 (66 mg, 0.09 mmol) in dry CH3OH (5
mL) was hydrogenated over 10% Pd/C (25 mg) under a flow of
H2 for 4 h. The catalyst was filtered off, and the filtrate was
concentrated. A solution of the residue in dry CH3OH (5 mL)
was stirred with 0.1 M methanolic sodium methoxide (0.5 mL)
for 2 h. Neutralization with prewashed Amberlite IR-118 (H+)
resin followed by filtration and concentration gave a residue
that was purified by chromatography (CHCl3/CH3OH, 3:1) to
yield 32 (31 mg, 84%) as a syrup: Rf 0.73 (CHCl3/CH3OH, 3:1);
1
[R]D +85° (c 1.0, H2O); H NMR (300 MHz, D2O, δ) 4.95 (d, 1
H, J ) 2.8 Hz, H-1′), 4.82 (d, 1 H, J ) 1.6 Hz, H-1), 4.29 (t, 1